Detalhe da pesquisa
1.
RNA-seq of newly diagnosed patients in the PADIMAC study leads to a bortezomib/lenalidomide decision signature.
Blood
; 132(20): 2154-2165, 2018 11 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-30181174
2.
Final analysis of survival outcomes in the phase 3 FIRST trial of up-front treatment for multiple myeloma.
Blood
; 131(3): 301-310, 2018 01 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-29150421
3.
The impact of cytogenetics on duration of response and overall survival in patients with relapsed multiple myeloma (long-term follow-up results from BSBMT/UKMF Myeloma X Relapse [Intensive]): a randomised, open-label, phase 3 trial.
Br J Haematol
; 185(3): 450-467, 2019 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-30729512
4.
Durable graft-versus-leukaemia effects without donor lymphocyte infusions - results of a phase II study of sequential T-replete allogeneic transplantation for high-risk acute myeloid leukaemia and myelodysplasia.
Br J Haematol
; 180(3): 346-355, 2018 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-29076145
5.
Using depth of response to stratify patients to front line Autologous Stem Cell Transplant: results of the phase II PADIMAC Myeloma Trial.
Br J Haematol
; 193(3): e19-e22, 2021 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-33715154
6.
Clinical outcome of coronavirus disease 2019 in haemato-oncology patients.
Br J Haematol
; 190(2): e64-e67, 2020 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-32420609
7.
Panobinostat plus bortezomib and dexamethasone versus placebo plus bortezomib and dexamethasone in patients with relapsed or relapsed and refractory multiple myeloma: a multicentre, randomised, double-blind phase 3 trial.
Lancet Oncol
; 15(11): 1195-206, 2014 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-25242045
8.
Long-term survival with low toxicity after allogeneic transplantation for acute myeloid leukaemia and myelodysplasia using non-myeloablative conditioning without T cell depletion.
Br J Haematol
; 162(4): 525-9, 2013 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-23718277
9.
T-cell replete fludarabine/cyclophosphamide reduced intensity allogeneic stem cell transplantation for lymphoid malignancies.
Br J Haematol
; 157(5): 580-5, 2012 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-22449197
10.
NK cells CD56bright and CD56dim subset cytokine loss and exhaustion is associated with impaired survival in myeloma.
Blood Adv
; 6(17): 5152-5159, 2022 09 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-35834731
11.
Association of genetic variants with patient reported quality of life and pain experience in patients in the UK NCRI Myeloma X Relapse [Intensive]) trial; an exploratory study.
Bone Marrow Transplant
; 57(10): 1507-1513, 2022 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-35768571
12.
How to Simplify the Evaluation of Newly Introduced Chemotherapeutic Interventions in Myeloma.
Clin Hematol Int
; 3(1): 27-33, 2021 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-34595464
13.
Toward a better management of older patients with acute myeloid leukemia.
Future Oncol
; 11(5): 715-8, 2015.
Artigo
em Inglês
| MEDLINE | ID: mdl-25757676
14.
Myeloblative therapy with autologous haematopoietic stem cell support as consolidation of first remission in acute myeloid leukaemia - very long follow-up.
Br J Haematol
; 167(5): 724-6, 2014 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-25074579
15.
Reversibility of symptomatic peripheral neuropathy with bortezomib in the phase III APEX trial in relapsed multiple myeloma: impact of a dose-modification guideline.
Br J Haematol
; 144(6): 895-903, 2009 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-19170677
16.
Patient-Reported Outcome Results From the Open-Label, Randomized Phase III Myeloma X Trial Evaluating Salvage Autologous Stem-Cell Transplantation in Relapsed Multiple Myeloma.
J Clin Oncol
; 37(19): 1617-1628, 2019 07 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-30969846
17.
Bortezomib, doxorubicin and dexamethasone (PAD) front-line treatment of multiple myeloma: updated results after long-term follow-up.
Br J Haematol
; 141(4): 512-6, 2008 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-18371113
18.
Optimal Management of Histone Deacetylase Inhibitor-Related Adverse Events in Patients With Multiple Myeloma: A Focus on Panobinostat.
Clin Lymphoma Myeloma Leuk
; 18(8): 501-507, 2018 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-29804873
19.
Bile acid malabsorption in patients with graft-versus-host disease of the gastrointestinal tract.
Br J Haematol
; 157(3): 403-7, 2012 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-22225419
20.
Mutation of CEBPA in familial acute myeloid leukemia.
N Engl J Med
; 351(23): 2403-7, 2004 Dec 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-15575056